Overview
Registration
Faculty
Agenda
Multimedia
View Archive

Accreditation/
Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Coherus BioSciences, Inc.

Not an official event of the 2019 ASCO Annual Meeting. Not sponsored, endorsed, or accredited by ASCO, CancerLinQ, or Conquer Cancer.

ASCO: Show Me the Data®: Leveraging the Evidence to Optimize Applications of Biosimilars in Cancer

ASCO: Show Me the Data®: Leveraging the Evidence to Optimize Applications of Biosimilars in Cancer


Sunday, June 2, 2019

Dinner and Registration: 6:30 PM – 7:00 PM
Program: 7:00 PM - 9:00 PM

Location
Hilton Chicago
Williford Room (Third Level)
720 S Michigan Ave
Chicago, IL 60605

Overview

Show Me the Data®: Leveraging the Evidence to Optimize Applications of Biosimilars in Cancer program will cover key clinical decision points on the use of biosimilars in cancer, focusing on the role of biosimilars in the treatment of HER2-positive breast cancer and in the management of patients with febrile neutropenia. With 19 approved biosimilars to-date in the U.S., and over 50 biosimilars approved in Europe, understanding the clinical trial data that supports the use of biosimilars across patient groups will enable participants in this program to confidently integrate these agents into their clinical practice. Real cases will be presented to the panel of international experts, where they will be challenged to substantiate each of their treatment decisions with the most appropriate clinical data that supports the care options they chose. Evidence presented will cover the comparative safety and efficacy data of biosimilars and their reference products. Participants in this program will be better equipped to address potential patient concerns regarding the safety and efficacy of these agents. Audience participation will be integrated throughout the program to encourage interaction with faculty and engagement with content.

Benefits of Attending

  • Understand the clinical evidence behind therapeutic biosimilars in breast cancer
  • Improve knowledge of supportive-care biosimilar agents across cancers types
  • Enhance ability to answer patients’ questions regarding biosimilar safety and efficacy, especially regarding comparative data for biosimilars and reference products
  • Increase awareness regarding oncology biosimilars that are in development that may impact clinical practice in the future

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Coherus BioSciences, Inc.

Not an official event of the 2019 ASCO Annual Meeting. Not sponsored, endorsed, or accredited by ASCO, CancerLinQ, or Conquer Cancer.

Target Audience

This educational program is directed toward medical oncologists interested in the treatment of cancers using biosimilars. Nurse practitioners, physician assistants, nurses, and other healthcare professionals involved in the treatment and management of patients using biosimilars will be invited to participate.

Educational Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Recognize the comprehensive and stringent testing, extending from preclinical to clinical data required to demonstrate the clinical comparability of biosimilars to reference drugs
  • Review clinical trial data in cancer supporting the use of biosimilars across patient groups to support integration of these agents into clinical practice
  • Address potential patient and clinician concerns regarding safety and efficacy in those who are incompletely informed about these agents
  • Outline pharmacovigilance considerations with biosimilars and ensure familiarity with the safety of both biosimilars and their corresponding reference products

Program Chair

Bradley J. MonkBradley J. Monk, MD, FACS, FACOG
Professor
Division of Gynecologic Oncology
Arizona Oncology (US Oncology Network)
University of Arizona College of Medicine
Phoenix Creighton University School of Medicine at St. Joseph’s Hospital
Medical Director
US Oncology Research Network - Gynecologic Program
Phoenix, AZ

Click to see all our ASCO programs!

Registration

2 Ways to Register
  1. Online: click here.
  2. Phone: Please call (888) 949-0045 or (609) 378-3701.
Physicians' Education Resource®
2 Clarke Drive
Suite 110
Cranbury, NJ 08512
 
Registration Fee - Free

For registration assistance, please email info@gotoper.com, or call (888) 949-0045 or (609) 378-3701.

Physicians' Education Resource®, LLC (PER®) fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.

Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited.  This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.    

By attending a PER® conference, meeting or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image"). By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.

Meeting information is accurate at the time of posting.

PER® complies with the Physician Payments Sunshine Act as a part of the Affordable Care Act (ACA). Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the ACA.



Register

You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information


Registration Information


Professional Information


Specialties*

Submit
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
     12
3456789
10111213141516
17181920212223
24252627282930
Filter By